NEW YORK, Oct. 25, 2021 – PRESS RELEASE – Columbia Care Inc., one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that it is the first licensed organization to offer whole flower to New York’s medical cannabis community. Whole flower will be available for purchase Oct. 26 at its Rochester dispensary and available on Oct. 27 in its other dispensaries across the state.

RELATED: New York Cannabis Control Board Dishes Out Whole Flower at First Meeting

In anticipation of the state’s Office of Cannabis Management’s Cannabis Control Board’s decision to expand medical cannabis products to include whole flower, the company amplified its cultivation and production efforts earlier this year. Through its existing indoor cultivation and production facility in Rochester, and upcoming harvest from its Long Island greenhouse facility, which recently began cultivation operations, the company will offer several high-quality, iconic whole flower strain options, beginning with Sour Kush.

“We are New York’s home team, so it shouldn’t come as a surprise that Columbia Care continues to be on the leading edge of the state’s cannabis program—from opening the first medical dispensary in New York State and New York City, to being the first to bring a critical, natural medicine in its most highly demanded and cost-effective form, whole flower, to New Yorkers,” Columbia Care CEO Nicholas Vita said. “This is a meaningful moment to us, and we are grateful to our team for their dedication to the New York market as well as to the state’s leadership and the Office of Cannabis Management for moving this program forward. This is the next step in the evolution of New York’s legal cannabis market, and we are committed to leading its continued forward progress.”

As one of 10 existing registered organizations in the state, Columbia Care intends to add an additional four medical dispensaries in New York, for a total of eight dispensaries in the state, three of which will be co-located with adult-use dispensaries, pending regulatory approval. The company will also offer flower in the coming months from its suite of brands including Seed & Strain, Classix and Triple Seven, pending regulatory approval.

For more information, visit